Hit-to-lead studies on benzimidazole inhibitors of ITK: Discovery of a novel class of kinase inhibitors

被引:56
作者
Snow, Roger J.
Abeywardane, Asitha
Campbell, Scot
Lord, John
Kashem, Mohammed A.
Khine, Hnin Hnin
King, Josephine
Kowalski, Jennifer A.
Pullen, Steven S.
Roma, Teresa
Roth, Gregory P.
Sarko, Christopher R.
Wilson, Noel S.
Winters, Michael P.
Wolak, John P.
Cywin, Charles L.
机构
[1] Boehringer Ingelheim Pharmaceut Inc, Med Chem, Ridgefield, CT 06877 USA
[2] Boehringer Ingelheim Pharmaceut Inc, Inflammat & Immunol, Ridgefield, CT 06877 USA
[3] Boehringer Ingelheim Pharmaceut Inc, Analyt Sci, Ridgefield, CT 06877 USA
[4] Johnson & Johnson PRD, Exton, PA 19341 USA
关键词
D O I
10.1016/j.bmcl.2007.04.045
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Benzimidazole 1 was identified as a selective inhibitor of ITK by high throughput screening. Hit-to-lead studies defined the SAR at all three substituents. Reversing the amide linkage at C6 led to 16, with a fivefold improvement of potency. This enhancement is rationalized by the conformational preference of the substituent. A model for the binding of the benzimidazoles to the ATP-binding site of ITK is proposed. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3660 / 3665
页数:6
相关论文
共 20 条
[1]   Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade [J].
Bunnell, SC ;
Diehn, M ;
Yaffe, MB ;
Findell, PR ;
Cantley, LC ;
Berg, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :2219-2230
[2]   Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors [J].
Das, J ;
Furch, JA ;
Liu, CJ ;
Moquin, RV ;
Lin, J ;
Spergel, SH ;
McIntyre, KW ;
Shuster, DJ ;
O'Day, KD ;
Penhallow, B ;
Hung, CY ;
Doweyko, AM ;
Kamath, A ;
Zhang, HJ ;
Marathe, P ;
Kanner, SB ;
Lin, TA ;
Dodd, JH ;
Barrish, JC ;
Wityak, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (14) :3706-3712
[3]   Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors [J].
Das, J ;
Liu, CJ ;
Moquin, RV ;
Lin, J ;
Furch, JA ;
Spergel, SH ;
McIntyre, KW ;
Shuster, DJ ;
O'Day, KD ;
Penhallow, B ;
Hung, CY ;
Kanner, SB ;
Lin, TA ;
Dodd, JH ;
Barrish, JC ;
Wityak, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (09) :2411-2415
[4]   Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells [J].
Fowell, DJ ;
Shinkai, K ;
Liao, XC ;
Beebe, AM ;
Coffman, RL ;
Littman, DR ;
Locksley, RM .
IMMUNITY, 1999, 11 (04) :399-409
[5]  
GIBSON S, 1993, BLOOD, V82, P1561
[6]   NMR INVESTIGATIONS ON BENZHETEROAZOLES .2. NMR INVESTIGATIONS OF N-ACYLATED 2-AMINOBENZIMIDAZOLES [J].
GRUNDEMANN, E ;
GRAUBAUM, H ;
MARTIN, D ;
SCHIEWALD, E .
MAGNETIC RESONANCE IN CHEMISTRY, 1986, 24 (01) :21-30
[7]   Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity [J].
Heyeck, SD ;
Wilcox, HM ;
Bunnell, SC ;
Berg, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25401-25408
[8]   Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors [J].
Kashem, Mohammed A. ;
Nelson, Richard M. ;
Yingling, Jeffrey D. ;
Pullen, Steven S. ;
Prokopowicz, Anthony S., III ;
Jones, Jessi Wildeson ;
Wolak, John P. ;
Rogers, George R. ;
Morelock, Maurice M. ;
Snow, Roger J. ;
Homon, Carol Ann ;
Jakes, Scott .
JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (01) :70-83
[9]   Functions of Bruton's tyrosine kinase in mast and B cells [J].
Kawakami, Y ;
Kitaura, J ;
Hata, D ;
Yao, LB ;
Kawakami, T .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (03) :286-290
[10]   Solid phase synthesis of chiral 2-amino-benzimidazoles [J].
Lee, JB ;
Doucette, A ;
Wilson, NS ;
Lord, J .
TETRAHEDRON LETTERS, 2001, 42 (14) :2635-2638